Jose Carrillo

1.7k total citations
41 papers, 795 citations indexed

About

Jose Carrillo is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Jose Carrillo has authored 41 papers receiving a total of 795 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Genetics, 19 papers in Pulmonary and Respiratory Medicine and 18 papers in Oncology. Recurrent topics in Jose Carrillo's work include Glioma Diagnosis and Treatment (27 papers), Brain Metastases and Treatment (14 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Jose Carrillo is often cited by papers focused on Glioma Diagnosis and Treatment (27 papers), Brain Metastases and Treatment (14 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Jose Carrillo collaborates with scholars based in United States, Netherlands and Belgium. Jose Carrillo's co-authors include Benjamin M. Ellingson, Whitney B. Pope, Albert Lai, Phioanh L. Nghiemphu, Santosh Kesari, Heidi Phillips, Samir Kharbanda, Jerry J. Lou, W. H. Yong and Parham Moftakhar and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Jose Carrillo

34 papers receiving 782 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jose Carrillo United States	12	439	249	225	212	176	41	795
Ziren Kong China	18	395 0.9×	381 1.5×	188 0.8×	231 1.1×	185 1.1×	47	878
Ryusuke Hatae Japan	17	554 1.3×	216 0.9×	154 0.7×	216 1.0×	295 1.7×	56	979
Mario Caccese Italy	17	450 1.0×	114 0.5×	224 1.0×	242 1.1×	253 1.4×	70	883
Corina Taitt United States	7	621 1.4×	134 0.5×	324 1.4×	659 3.1×	230 1.3×	14	1.2k
Manuela Silginer Switzerland	16	361 0.8×	74 0.3×	101 0.4×	344 1.6×	415 2.4×	31	1.0k
Almuth F. Keßler Germany	16	275 0.6×	129 0.5×	101 0.4×	209 1.0×	203 1.2×	57	704
David P. Kodack United States	10	220 0.5×	111 0.4×	441 2.0×	474 2.2×	354 2.0×	13	1.0k
K. Jason South Korea	17	192 0.4×	69 0.3×	168 0.7×	249 1.2×	354 2.0×	48	814
Koji Oka Japan	9	351 0.8×	76 0.3×	138 0.6×	227 1.1×	310 1.8×	23	727
Nikhil Sebastian United States	11	181 0.4×	85 0.3×	234 1.0×	179 0.8×	142 0.8×	46	579

Countries citing papers authored by Jose Carrillo

Since Specialization

Citations

This map shows the geographic impact of Jose Carrillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jose Carrillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jose Carrillo more than expected).

Fields of papers citing papers by Jose Carrillo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jose Carrillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jose Carrillo. The network helps show where Jose Carrillo may publish in the future.

Co-authorship network of co-authors of Jose Carrillo

This figure shows the co-authorship network connecting the top 25 collaborators of Jose Carrillo. A scholar is included among the top collaborators of Jose Carrillo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jose Carrillo. Jose Carrillo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bota, Daniela A., David Piccioni, Christopher Duma, et al.. (2025). Phase 2 trial of personal dendritic cell vaccines in newly diagnosed glioblastoma: 3-year follow-up and correlations with survival. Human Vaccines & Immunotherapeutics. 21(1). 2556591–2556591.

Khagi, Simon, Jose Carrillo, David Park, et al.. (2025). CTIM-23. FIRST-IN-HUMAN IMMUNOTHERAPY TARGETING LYMPHOPENIA IN RECURRENT GLIOBLASTOMA MULTIFORM (GBM): NAI AND PD-L1 T-HANK PLUS BEVACIZUMAB WITH COMPLETE RESPONSE. Neuro-Oncology. 27(Supplement_5). v119–v119.

Juarez, Tiffany, Jose Carrillo, Naveed Wagle, et al.. (2024). A phase I dose-escalation study of pulsatile afatinib in patients with recurrent or progressive brain cancer. Neuro-Oncology Advances. 6(1). vdae049–vdae049.

Blouw, Barbara, Tony J. Pircher, Julie Ann Mayer, et al.. (2024). A Microfluidic, Multi-Antibody Cell Capture Method to Evaluate Tumor Cells in Cerebrospinal Fluid in Patients With Suspected Leptomeningeal Metastases. Archives of Pathology & Laboratory Medicine. 149(3). 242–252. 1 indexed citations

Carrillo, Jose, Charles H. Redfern, Ivan Babić, et al.. (2024). A phase 1 dose escalation of pritumumab in patients with refractory or recurrent gliomas or brain metastases. Neuro-Oncology Advances. 6(1). vdae166–vdae166. 2 indexed citations

Darabi, Sourat, Joanne Xiu, Santosh Kesari, et al.. (2023). Capicua (CIC) mutations in gliomas in association with MAPK activation for exposing a potential therapeutic target. Medical Oncology. 40(7). 197–197. 10 indexed citations

Kesari, Santosh, Naveed Wagle, Jose Carrillo, et al.. (2023). Pilot Study of High-Dose Pemetrexed in Patients with Progressive Chordoma. Clinical Cancer Research. 30(2). 323–333. 3 indexed citations

Kesari, Santosh, Alexandre Wojcinski, Jose Carrillo, et al.. (2023). Prospective phase I study of checkpoint blockade for the treatment of patients with newly diagnosed high-grade glioma prior to radiochemotherapy: Results of nivolumab plus ipilimumab treatment arm.. Journal of Clinical Oncology. 41(16_suppl). 2057–2057. 1 indexed citations

Carrillo, Jose, et al.. (2023). Phase 1 study of pritumumab in brain cancer.. Journal of Clinical Oncology. 41(16_suppl). 2053–2053. 1 indexed citations

10.

Carrillo, Jose, et al.. (2022). Enhanced Progression-Free Survival in a Phase 2 Trial of Personal Dendritic Cell Vaccines in Patients with Newly Diagnosed Glioblastoma. 7(3). 1 indexed citations

11.

Weidhaas, Joanne B., Nicholas De Marco, Anusha Kalbasi, et al.. (2022). Germline biomarkers predict toxicity to anti-PD1/PDL1 checkpoint therapy. Journal for ImmunoTherapy of Cancer. 10(2). e003625–e003625. 17 indexed citations

12.

Bota, Daniela A., Thomas H. Taylor, David Piccioni, et al.. (2022). Phase 2 study of AV-GBM-1 (a tumor-initiating cell targeted dendritic cell vaccine) in newly diagnosed Glioblastoma patients: safety and efficacy assessment. Journal of Experimental & Clinical Cancer Research. 41(1). 344–344. 38 indexed citations

13.

Kumthekar, Priya, Shou‐Ching Tang, Andrew Brenner, et al.. (2020). ANG1005, a Brain-Penetrating Peptide–Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain Metastases. Clinical Cancer Research. 26(12). 2789–2799. 178 indexed citations

14.

Wagle, Naveed, et al.. (2020). Characterization of molecular pathways for targeting therapy in glioblastoma. Chinese Clinical Oncology. 9(6). 77–77. 6 indexed citations

15.

Carrillo, Jose & Santosh Kesari. (2019). Is re-radiation for glioblastoma after progression associated with increased survival: to treat or not to treat?. Translational Cancer Research. 8(1). 4–6. 2 indexed citations

16.

Bota, Daniela A., Jose Carrillo, Frank P. K. Hsu, et al.. (2018). Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma : interim results and correlations with CD4+ T-lymphocyte counts. JAMA Oncology. 7(3). 3 indexed citations

17.

Kumthekar, Priya, Shou‐Ching Tang, Andrew Brenner, et al.. (2016). OS7.2 A Phase II Study of ANG1005, a novel BBB/BCB Penetratant Taxane in Patients with Recurrent Brain Metastases and Leptomeningeal Carcinomatosis from Breast Cancer. Neuro-Oncology. 18(suppl_4). iv16–iv16. 7 indexed citations

18.

Ellingson, Benjamin M., Timothy F. Cloughesy, Thiri Zaw, et al.. (2012). Functional diffusion maps (fDMs) evaluated before and after radiochemotherapy predict progression-free and overall survival in newly diagnosed glioblastoma. Neuro-Oncology. 14(3). 333–343. 63 indexed citations

19.

Carrillo, Jose, et al.. (2012). Alternative Chemotherapeutic Agents: Nitrosoureas, Cisplatin, Irinotecan. Neurosurgery Clinics of North America. 23(2). 297–306. 18 indexed citations

20.

Carrillo, Jose, Albert Lai, Phioanh L. Nghiemphu, et al.. (2012). Relationship between Tumor Enhancement, Edema,IDH1Mutational Status,MGMTPromoter Methylation, and Survival in Glioblastoma. American Journal of Neuroradiology. 33(7). 1349–1355. 235 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact